retatrutide clinical trial doses Dosing Schedule: Proven 2026 Guide Starting Phase 3b Clinical Trial

The energy dip that sometimes accompanies the first 24 hours post-injection happens during the day when you can manage it with light activity, caffeine if tolerated, and strategic eating

Any supply outside of an approved clinical trial setting is not sanctioned by UK regulatory authorities

You receive an individualized plan

The 8 mg dose produced mean weight loss of approximately 22.8%, while the 4 mg dose achieved about 17.3% weight reduction

Retatrutide is an investigational medication currently being studied for its potential to help people achieve significant weight loss and better manage type 2 diabetes

Animal studies have demonstrated that combination therapies involving GLP-1 receptor agonists and agents targeting lipid metabolism pathways produce marked reductions in liver fat content, downregulate lipogenic enzymes, and upregulate proteins involved in lipid oxidation (41)